Lymphocytes, Apoptosis and Sepsis: Making the Jump from Mice to Humans

Overview

Journal Crit Care

Specialty Critical Care

Date 2009 Feb 17

PMID 19216722

Citations 36

Authors

John D Lang

Gustavo Matute-Bello

Affiliations

Soon will be listed here.

Abstract

Sepsis is an important clinical problem with a mortality rate of 20% to 30%. Lymphocyte apoptosis has been recognized as an important step in the pathogenesis of experimental sepsis, by inducing a state of 'immune paralysis' that renders the host vulnerable to invading pathogens. The importance of lymphocyte apoptosis in human disease is now confirmed by Weber and colleagues, who demonstrate extensive apoptosis in circulating lymphocytes from patients with severe sepsis. Weber and colleagues' data set the basis for further studies aimed at modulating lymphocyte apoptosis in sepsis.

Citing Articles

Exploring the relationship between sepsis and Golgi apparatus dysfunction: bioinformatics insights and diagnostic marker discovery.

Ma W, Liu X, Yu R, Song J, Hou L, Guo Y Front Genet. 2025; 16:1483493.

PMID: 39981259 PMC: 11839613. DOI: 10.3389/fgene.2025.1483493.

Prognostic significance of blood immune cells in children with sepsis and establishment of a predictive model for PICU mortality: a retrospective study.

He M, Meng Q, Wei Z, Yang Z Front Pediatr. 2024; 12:1455216.

PMID: 39726536 PMC: 11669697. DOI: 10.3389/fped.2024.1455216.

Macrophage activation syndrome in Sepsis: from pathogenesis to clinical management.

Chen S, Zhang C, Luo J, Lin Z, Chang T, Dong L Inflamm Res. 2024; 73(12):2179-2197.

PMID: 39404874 DOI: 10.1007/s00011-024-01957-7.

The value of lymphocyte-to-C-reactive protein ratio for predicting clinical outcomes in patients with sepsis in intensive care unit: a retrospective single-center study.

Song C, Hu Z, Zhang J Front Mol Biosci. 2024; 11:1429372.

PMID: 39347502 PMC: 11427359. DOI: 10.3389/fmolb.2024.1429372.

Identification of apoptosis-immune-related gene signature and construction of diagnostic model for sepsis based on single-cell sequencing and bulk transcriptome analysis.

Sun Z, Hu Y, Qu J, Zhao Q, Gao H, Peng Z Front Genet. 2024; 15:1389630.

PMID: 38894720 PMC: 11183325. DOI: 10.3389/fgene.2024.1389630.

References

Peck-Palmer O, Unsinger J, Chang K, Davis C, McDunn J, Hotchkiss R . Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol. 2008; 83(4):1009-18. DOI: 10.1189/jlb.0807528. View

Abraham E, Laterre P, Garbino J, Pingleton S, Butler T, Dugernier T . Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med. 2001; 29(3):503-10. DOI: 10.1097/00003246-200103000-00006. View

Hotchkiss R, Tinsley K, Swanson P, Schmieg Jr R, Hui J, Chang K . Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol. 2001; 166(11):6952-63. DOI: 10.4049/jimmunol.166.11.6952. View

Hotchkiss R, Swanson P, Cobb J, Jacobson A, Buchman T, KARL I . Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit Care Med. 1997; 25(8):1298-307. DOI: 10.1097/00003246-199708000-00015. View

Docke W, RANDOW F, Syrbe U, Krausch D, Asadullah K, Reinke P . Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997; 3(6):678-81. DOI: 10.1038/nm0697-678. View

Wang S, Huang K, Lin Y, Lei H . Sepsis-induced apoptosis of the thymocytes in mice. J Immunol. 1994; 152(10):5014-21. View

Angus D, Lidicker J, Clermont G, Carcillo J, Pinsky M . Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29(7):1303-10. DOI: 10.1097/00003246-200107000-00002. View

Chang K, Unsinger J, Davis C, Schwulst S, Muenzer J, Strasser A . Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J. 2007; 21(3):708-19. DOI: 10.1096/fj.06-6805com. View

Opal S, Fisher Jr C, Dhainaut J, Vincent J, Brase R, Lowry S . Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med. 1997; 25(7):1115-24. DOI: 10.1097/00003246-199707000-00010. View

10.

Weber S, Schewe J, Lehmann L, Muller S, Book M, Klaschik S . Induction of Bim and Bid gene expression during accelerated apoptosis in severe sepsis. Crit Care. 2008; 12(5):R128. PMC: 2592767. DOI: 10.1186/cc7088. View

11.

Martin G, Mannino D, Eaton S, Moss M . The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003; 348(16):1546-54. DOI: 10.1056/NEJMoa022139. View

12.

Volk H, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller J . Monocyte deactivation--rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996; 22 Suppl 4:S474-81. DOI: 10.1007/BF01743727. View

13.

Hotchkiss R, Nicholson D . Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol. 2006; 6(11):813-22. DOI: 10.1038/nri1943. View

14.

Angus D, Birmingham M, Balk R, Scannon P, Collins D, Kruse J . E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA. 2001; 283(13):1723-30. DOI: 10.1001/jama.283.13.1723. View